Download Full Text (744 KB)
• The purpose of this study is to explore the role of gut microbiome alterations in the treatment of anxiety and depression. • There are multiple pathological pathways that lead to the development of anxiety and depression. • Research shows a link between pathologic bacteria and low grade inflammation. This causes a disruption of neurotransmitters that are current targets of pharmacological treatment of depression and anxiety. • Transfer of “pathogenic” bacteria caused increased symptoms of anxiety and depression. • Treatment with probiotics and “protective” bacteria showed decreased BDI scores and improved symptoms. • Studies were small but show need for further research
Physician Assistant Studies
Date of Work
Gut Microbiome, anxiety, depression, Pathogenic Bacteria, mood disorders, chronic stress
Medicine and Health Sciences
Bachman-Williams, Alexandria, "The Gut-Brain Axis: Treating Depression Through Microbiome Alterations" (2020). Physician Assistant Scholarly Project Posters. 162.